Literature DB >> 29241690

Nuclear positioning in skeletal muscle.

William Roman1, Edgar R Gomes2.   

Abstract

Skeletal muscle cells possess a unique cellular architecture designed to fulfill their contractile function. Muscle cells (also known as myofibers) result from the fusion of hundreds of myoblasts and grow into a fiber of several centimeters in length. Cellular structures gradually become organized during muscle development to raise a mature contractile cell. A hallmark of this singular cell architecture is the position of nuclei at the periphery of the myofiber, below the plasma membrane. Nuclei in myofibers are evenly distributed except in specialized regions like the neuromuscular or myotendinous junctions. Disruption of nuclear positioning results in hindered muscle contraction and occurs in a multitude of muscle disorders as well as in regenerative myofibers. We will explore in this review the step by step nuclear migrations during myogenesis for nuclei to reach their evenly distributed anchored position at the periphery.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cytoskeleton; Muscle development; Muscle disorders; Myogenesis; Nuclear movement

Mesh:

Year:  2017        PMID: 29241690     DOI: 10.1016/j.semcdb.2017.11.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  51 in total

Review 1.  Mechanics of nuclear membranes.

Authors:  Ashutosh Agrawal; Tanmay P Lele
Journal:  J Cell Sci       Date:  2019-07-15       Impact factor: 5.285

Review 2.  The skeletal muscle fiber: a mechanically sensitive cell.

Authors:  Luke A Olsen; Justin X Nicoll; Andrew C Fry
Journal:  Eur J Appl Physiol       Date:  2019-01-05       Impact factor: 3.078

Review 3.  Getting into Position: Nuclear Movement in Muscle Cells.

Authors:  Mafalda Azevedo; Mary K Baylies
Journal:  Trends Cell Biol       Date:  2020-01-30       Impact factor: 20.808

Review 4.  [Research advances in limb-girdle muscular dystrophy type 2Q].

Authors:  Min Zhang; Dan Lan
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

5.  Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.

Authors:  J Spencer Hauck; Jeovanna Lowe; Neha Rastogi; Kevin E McElhanon; Jennifer M Petrosino; Kyra K Peczkowski; Ashlee N Chadwick; Jonathan G Zins; Federica Accornero; Paul M L Janssen; Noah L Weisleder; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

6.  Nuclear Scaling Is Coordinated among Individual Nuclei in Multinucleated Muscle Fibers.

Authors:  Stefanie E Windner; Angelika Manhart; Amelia Brown; Alex Mogilner; Mary K Baylies
Journal:  Dev Cell       Date:  2019-03-21       Impact factor: 12.270

7.  Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.

Authors:  Jordan Blondelle; Kavya Tallapaka; Jane T Seto; Majid Ghassemian; Madison Clark; Jenni M Laitila; Adam Bournazos; Jeffrey D Singer; Stephan Lange
Journal:  JCI Insight       Date:  2019-04-16

8.  Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin.

Authors:  Xingxing Kong; Ting Yao; Peng Zhou; Lawrence Kazak; Danielle Tenen; Anna Lyubetskaya; Brian A Dawes; Linus Tsai; Barbara B Kahn; Bruce M Spiegelman; Tiemin Liu; Evan D Rosen
Journal:  Cell Metab       Date:  2018-08-02       Impact factor: 27.287

9.  G-quadruplex ligands mediate downregulation of DUX4 expression.

Authors:  Lukasz Ciszewski; Ngoc Lu-Nguyen; Alex Slater; Andrew Brennan; Huw E L Williams; George Dickson; Mark S Searle; Linda Popplewell
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

10.  Nesprin-2 accumulates at the front of the nucleus during confined cell migration.

Authors:  Patricia M Davidson; Aude Battistella; Théophile Déjardin; Timo Betz; Julie Plastino; Nicolas Borghi; Bruno Cadot; Cécile Sykes
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.